RTN4
Basic information
Region (hg38): 2:54972187-55112621
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RTN4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 75 | 86 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 76 | 11 | 6 |
Variants in RTN4
This is a list of pathogenic ClinVar variants found in the RTN4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-54973169-C-T | not specified | Uncertain significance (May 09, 2023) | ||
2-54973170-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
2-54973569-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
2-54973570-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
2-54973590-T-C | not specified | Uncertain significance (Sep 29, 2023) | ||
2-54973828-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
2-54973837-A-G | not specified | Uncertain significance (Nov 14, 2023) | ||
2-54973865-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
2-54974710-T-G | not specified | Uncertain significance (Mar 17, 2023) | ||
2-54974736-T-C | not specified | Uncertain significance (Mar 16, 2022) | ||
2-54982570-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
2-54982573-C-T | not specified | Uncertain significance (Apr 17, 2023) | ||
2-54982589-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
2-54982628-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
2-54982646-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
2-54987503-C-G | Likely benign (Mar 01, 2023) | |||
2-54987537-C-A | not specified | Uncertain significance (Jan 03, 2024) | ||
2-55025104-C-G | not specified | Uncertain significance (Mar 04, 2024) | ||
2-55025123-T-C | Benign (Apr 16, 2018) | |||
2-55025158-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
2-55025166-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
2-55025218-G-C | Likely benign (May 14, 2018) | |||
2-55025265-G-A | not specified | Likely benign (Jan 20, 2023) | ||
2-55025278-T-G | Likely benign (May 14, 2018) | |||
2-55025295-G-A | not specified | Uncertain significance (Aug 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RTN4 | protein_coding | protein_coding | ENST00000337526 | 9 | 140433 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.453 | 0.547 | 125735 | 0 | 12 | 125747 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.12 | 634 | 560 | 1.13 | 0.0000264 | 7698 |
Missense in Polyphen | 154 | 143.5 | 1.0732 | 1924 | ||
Synonymous | -0.118 | 220 | 218 | 1.01 | 0.0000112 | 2377 |
Loss of Function | 4.35 | 8 | 36.3 | 0.220 | 0.00000162 | 578 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000443 | 0.0000439 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS. Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Isoform 2 reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration. Isoform 2 and isoform 3 inhibit BACE1 activity and amyloid precursor protein processing. Induces the formation and stabilization of endoplasmic reticulum (ER) tubules (PubMed:25612671, PubMed:24262037, PubMed:27619977). Regulates membrane morphogenesis in the ER by promoting tubular ER production (PubMed:27619977). Influences NE expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins (PubMed:26906412). {ECO:0000250|UniProtKB:Q99P72, ECO:0000269|PubMed:10667797, ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:16965550, ECO:0000269|PubMed:24262037, ECO:0000269|PubMed:25612671, ECO:0000269|PubMed:26906412, ECO:0000269|PubMed:27619977}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Spinal Cord Injury;Signal Transduction;Death Receptor Signalling;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;p75(NTR)-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.235
Intolerance Scores
- loftool
- 0.805
- rvis_EVS
- 1.85
- rvis_percentile_EVS
- 97.13
Haploinsufficiency Scores
- pHI
- 0.407
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.435
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.836
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rtn4
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Zebrafish Information Network
- Gene name
- rtn4b
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- immature
Gene ontology
- Biological process
- blastocyst formation;apoptotic process;axonal fasciculation;positive regulation of epithelial cell migration;cerebral cortex radial glia guided migration;negative regulation of cell growth;negative regulation of axon extension;positive regulation of mammary gland epithelial cell proliferation;regulation of apoptotic process;negative regulation of axonogenesis;protein stabilization;nuclear pore complex assembly;positive regulation of protein kinase B signaling;cardiac epithelial to mesenchymal transition;endoplasmic reticulum tubular network organization;endoplasmic reticulum tubular network formation;positive regulation of protein localization to endoplasmic reticulum;positive regulation of ERBB3 signaling pathway;endoplasmic reticulum tubular network membrane organization;regulation of branching morphogenesis of a nerve
- Cellular component
- nuclear envelope;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;postsynaptic density;integral component of endoplasmic reticulum membrane;cell projection;neuronal cell body;endoplasmic reticulum tubular network;endoplasmic reticulum tubular network membrane
- Molecular function
- RNA binding;protein binding;ubiquitin protein ligase binding;cadherin binding